Insider filing · AXGN
Erick Wayne DeVinney
Chief Innovation Officer
profile →
Axogen, Inc.
AXGN · Healthcare · 30 filings in 24 months
ticker →
Erick Wayne DeVinney sold $264K of Axogen (AXGN)
Executed Mar 19 2025, disclosed Mar 19 2025, the same day.
Value, as filed
$264K
15,111 sh × $17.50
Executed
Mar 19 2025
the trade date, as filed
Disclosed
Mar 19 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EDErick Wayne DeVinney (Chief Innovation Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Axogen, Inc. (AXGN). The largest single filing was $609K of AXGN (19,517 sh × $31.21, as filed), executed Dec 9 2025.
The name
AXGNHealthcare · Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerv…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Erick Wayne DeVinney in AXGN
AXGNSALE
Axogen, Inc.
$171K5,221 sh × $32.84
Exec Mar 16
Filed Mar 18 · 5:30 PM ET AXGNSALE Axogen, Inc. $609K
19,517 sh × $31.21
Exec Dec 9 2025
Filed Dec 10 2025 · 5:30 PM ET